Early ID & risk stratification
Professor Grote reflects on the clinical reception, implementation and impact of the Swedish OSA treatment matrix since its 2021 rollout.
Professor Grote explains how symptoms and comorbidities are evaluated within the context of the Swedish treatment matrix.
Professor Grote discusses the role of national and European registries in advancing sleep apnea care.
Scalable diagnosis & access
Professor Grote sheds light on the rising demand for OSA treatment and the attendant strain on health systems.
Professor Grote discusses how involving general practitioners more directly in OSA care could help improve access to timely OSA care.
Privacy|Terms of use |©2026 Resmed|All rights reserved